1. Citreoviridin was a potent inhibitor of the soluble mitochondrial ATPase (adenosine triphosphatase) similar to the closely related aurovertins B and D. 2. Citreoviridin inhibited the following mitochondrial energy-linked reactions also: ADP-stimulated respiration in whole mitochondria from ox heart and rat liver; ATP-driven reduction of NAD+ by succinate; ATP-driven NAD transhydrogenase and ATPase from ox heart submitochondrial particles. 3. The dissociation constant (KD) calculated by a simple law-of-mass-action treatment for the citreoviridin-ATPase complex was 0.5-4.2pM for ox-heart mitochondrial preparations and 0.15pM for rat liver mitochondria.
its inhibitory potency considerably. 6 . No significant enhancement of fluorescence was observed when citreoviridin interacted with the mitochondrial ATPase.
Citreoviridin is a toxic secondary metabolite isolated from several Penicillium species (Uraguchi, 1971; Nagel et al., 1972a) . Its structure was elucidated by Sakabe et al. (1964) . The absolute configuration has recently been determined (see structure Ia; L. J. Mulheirn, unpublished work) .
Citreoviridin has a close structural similarity to the aurovertins (Mulheirn et al., 1974) , which have been shown to be potent inhibitors of the mitochondrial ATP synthetase system (Lardy et al., 1964; Lenaz, 1965; Lee & Ernster, 1968; Roberton et al., 1968; Osselton et al., 1974; Ebel & Lardy, 1975) .
In the present paper we show that citreoviridin and, to a lesser extent, citreoviridin monoacetate (structure Ib), inhibit various activities of the mitochondrial energy-conservation system in a manner similar to that of the aurovertins. Citreoviridin diacetate (structure Ic) is an ineffective inhibitor of the mitochondrial ATPase and its associated activities.
A simple model for the interaction of citreoviridin with the ATPase is presented to resolve the apparently anomalous differential sensitivity of the ATPase and the ATP synthetase to citreoviridin.
Abbreviations used: ATPase, adenosine triphosphatase (EC 3.6.1.3); h.p.l.c., high-performance liquid chromatography. 
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Experimental Citreoviridin A sample of citreoviridin was obtained from Dr. D. W. Nagel and Dr. P. S. Steyn, C.S.I.R., Pretoria, South Africa. After recrystallization from methanol, the citreoviridin sample used for inhibition studies gave only a single peak on analysis by h.p.l.c. with chloroform/acetone (7:1, v/v) (see below). Crude samples of citreoviridin and solutions stored for a long time showed two poorly resolved peaks on h.p.l.c. The major peak, which was eluted first, corresponded to pure citreoviridin; it is probable that the second peak represented isocitreoviridin, which has not been well characterized but is considered to have a cis-double bond in the conjugated tetraene system (Nagel et al., 1972a (1, M-CH3CO2H), 313 (12), 297 (11), 296 (14) , 259 (20), 258 (27), 187 (26), 169 (50) , 154 (20) , 139 (100 %, pyrone moiety, C7H703), 127 (66) [values in parentheses are percentage intensities of peaks in relation to the most intense (100 %) in mass spectrum]. Citreoviridin monoacetate has been briefly described by Sakabe et al. (1964) .
Citreoviridin diacetate
The procedure of Steglich & Hofle (1969) for acetylation of tertiary hydroxyl groups was adopted. A citreoviridin sample obtained from Dr. Y. Ueno, University ofTokyo, Tokyo, Japan (4.5 mg, 11 .2gmol) was treated with NN-dimethylpyridin-4-amine (1.2mg, 10,umol), redistilled acetic anhydride (54mg, 0.96mmol) and triethylamine (22mg, 0.22mmol; stored over KOH pellets). After 2.5 days at room temperature (20°C) in the dark, in a stoppered flask, the solution was diluted with 1 ml of chloroform, washed with 1 ml of water and twice with 1 ml of satd. NaCl. The chloroform layer was dried over anhydrous MgSO4 and then applied to two preparative 2mm-thick silica-gel plates 
Solutions of citreoviridin and its derivatives
Ethanolic solutions were stored in the dark at -20°C. The concentrations of citreoviridin and its acetates were estimated by using the published value of 6383= 44000 litre * mol-' -cm--.
Mitochondria
Rat liver mitochondria were prepared from young adult Wistar rats, starved overnight (Johnson & Lardy, 1967) . They were suspended in 0.25M-sucrose and were stored at 0°C. They remained coupled up to about 5 h from preparation.
Ox heart mitochondria were prepared from minced ox heart treated with Nagarse (proteolytic enzyme from Digby Chemical Service, London SWlW 9QU, U.K.) (Beinert, 1964) . The mitochondria were isolated by differential centrifugation and then washed and resuspended in 0,25M-sucrose/ 1978 lOmM-Tris/H2SO4, pH7.7. Ox heart mitochondria stored at 0°C could be used for coupled respiration studies for up to 1 week.
Submitochondrial particles
The method used was derived from that described by Hansen & Smith (1964) . Suspensions of ox heart mitochondria stored at -20°C were thawed and made 4mM in MgSO4, 1 mm in sodium succinate and 1 mM in ATP. After two cycles of freezing and thawing, the suspension was centrifuged at lOOOOg for 0min. The pellet was resuspended at 10mg of protein/ml in 0.25 M-sucrose/1 mM-ATP/1 mM-sodium succinate/ 15mM-MgSO4/20mM-Tris, adjusted to pH7.7 with sucrose/lOmM-KCI/25mM-sodium succinate/20mM-Tris/H2SO4/2mM-MgCl2/5 mM-KH2PO4, final pH 7.4, for rat liver mitochondria or (b) 0.15M-KCI/5mm-sodium L-glutamate/5mM-sodium L-malate/3mm-EGTA/lOmM-Na2HPO4/NaH2PO4buffer, pH 6.8, for ox heart mitochondria. A suitable volume of mitochondrial suspension (about 1-2mg of protein) was added, followed by a portion of a solution of the inhibitor in ethanol, or ethanol for the control. This gave a State-4 respiration rate (Chance & Williams, 1955 . This mitochondrial suspension cooled in ice was pumped at 20ml/min once through the flow cell attached to the probe of a Rapidis F400 flow-through ultrasonic disintegrator (Ultrasonics Ltd., Shipley, Yorks. BD18 2BN, U.K.) set at an amplitude of 22,um and power of 110W. The flow cell (internal vol. 1 ml) was cooled by water circulation at 0°C. The suspension was exposed to ultrasonic power for an average of 3s. After centrifuging at IOOOOg for 10min, the supernatant was centrifuged at 1000OOg for 30min. The pellet was washed by centrifugation with 0.25 M-sucrose/lOmM-Tris/H2SO4, pH7.7, and finally suspended in that buffer at 30-40mg of protein/ml. Portions (1 ml) were stored at -20°C and used immediately after thawing.
Soluble ATPase
Soluble ATPase as prepared from ox heart submitochondrial particles by the chloroform method (Beechey et al., 1975) was dissolved in 0.25 M-sucrose/ IOmM-Tris/H2SO4 (pH 7.7)/1 mM-EDTA. This buffer was changed to 25 mM-Tris/H_SO4 (pH 7.7)/I mm-EDTA by continuous filtration through an XM-100A membrane in an Amicon pressure ultrafiltration cell (Amicon Ltd., High Wycombe, Bucks., U.K.). Samples (0.15ml) of the resulting solution at 1.7mg of protein/ml were freeze-dried and stored over silica gel at -15°C. Addition ofwater at 20°C gave solutions of ATPase without loss of activity. These were stored at 20°C and used within 8 h.
Assay procedures for energy-linked reactions ADP-stimulated respiration. Respiration rates were measured at 30°C with a Clark-type oxygen electrode (Chappell, 1964 ATP was added to a final concentration of 2mM to start the reaction. Oxidation of NADH was followed as above.
Protein determination
The protein concentrations of particulate preparations were estimated by the biuret method in the presence of 0.27% (w/v) sodium deoxycholate (Dawson et al., 1969) . Soluble ATPase concentrations were estimated by a modified Lowry technique (Beechey et al., 1975) .
H.p.l.c.
A stainless-steel column (25cm x 0.95 cm) packed with 10gm-diameter silica gel (Partisil 10; Whatman, Maidstone, Kent, U.K.) was used as described by Webber & McKerrell (1976) . A pressure of about 3.8 MPa (4001b/in2) gave a flow rate of 4-5ml/min. Chloroform solutions (up to 500,l) were injected on to the column. The eluent was monitored at 380nm in an 8,ul spectrophotometric flow cell (model CE212; Cecil Instruments Ltd., Cambridge, U.K. Inhibitor concentration [I] (nmol/mg of protein) Fig. 1 . Inhibition curves for citreoviridin and its acetates against energy-linked enzymes activities from ox heart mitochondria Enzyme activities were assayed as described in the Experimental section. The effects of citreoviridin, citreoviridin monoacetate and citreoviridin diacetate were so great as to cause technical problems owing to its lack of solubility in aqueous systems and its absorbance at 340nm. Table 2 shows that citreoviridin and its monoacetate also inhibited ADP-stimulated respiration in rat liver mitochondria. Citreoviridin was a more potent inhibitor than the monoacetate (KD= 0.15 and 0.68.uM respectively). The inhibitions were relieved by 2,4-dinitrophenol. The affinity of citreoviridin was higher for the rat liver mitochondrial ATPase molecule than for the ox heart enzyme. Fig. 1 shows that complete inhibition of ADPstimulated respiration and of ATP-driven reversed electron transport could be achieved with citreoviridin and citreoviridin monoacetate. Inhibition of the membrane-bound and soluble ATPases and ofthe ATP-driven transhydrogenase, however, reached only 80-87 % even at high inhibitor concentrations.
Stimulation of the ATPase activity
Reproducible stimulation of the soluble ATPase activity up to 26% higher than controls was found with citreoviridin diacetate (see Fig. 1 c) (Mulheirn et al., 1974) . Table 2 shows that the octahydro derivative was a much less effective inhibitor than citreoviridin monoacetate when assayed against ADP-stimulated respiration in rat liver mitochondria. Hydrogenation to decahydrocitreoviridin monoacetate further decreased the inhibitory potency. For each derivative, 2,4-dinitrophenol was able to relieve the inhibition of ADP-stimulated respiration. (Ilb) when citreoviridin was added to ox heart submitochondrial particles or soluble ATPase in buffer.
Discussion
Citreoviridin has been shown to inhibit ADPstimulated respiration in mitochondria. The inhibition is relieved by uncouplers. Citreoviridin also inhibits both the membrane-bound and soluble ATPases and two partial reactions of mitochondrial energy conservation, the ATP-driven reduction of NAD+ by succinate and the ATP-driven NAD transhydrogenase (Fig. 1) . The inhibition of the soluble ATPase by citreoviridin localizes its site of action and distinguishes it from the class of membrane-directed ATPase inhibitors exemplified by oligomycin (Linnett & Beechey, 1978) . The mode of action of citreoviridin appears to be similar to that of aurovertins B and D (Kagawa & Racker, 1966; Roberton et al., 1967; Lambeth & Lardy, 1971; Chang & Penefsky, 1973; Catterall & Pedersen, 1974; Beechey et al., 1975; Ebel & Lardy, 1975) , as might be expected from the similarities in their structures (Mulheirn et al., 1974) . Citreoviridin and the aurovertins all contain pyrone-polyene moieties. The remaining features of each molecule are closely related both stereochemically and biosynthetically (Nagel et al., 1972b It has been observed frequently that the mitochondrial ATP synthetase is apparently much more sensitive to the aurovertins than are those activities that rely on the hydrolysis of ATP (Lardy et al., 1964; Lenaz, 1965; Lee & Ernster, 1968; Roberton et al., 1968; Bertina et al., 1973; Conover & Schneider, 1976) . The present data show that the inhibition by citreoviridin of the forward and reverse reactions of the ATPase molecule also appears anomalous. The simple treatment described by Linnett et al. Vol. 170 (1977) (Straus & Goldstein, 1943) . The dissociation constants calculated in Table 1 for n = 1 are not changed significantly for n 3.
Monoacetylation of citreoviridin decreases the inhibitory potency somewhat, but further acetylation to citreoviridin diacetate greatly decreases the affinity for the inhibitory site on the ATPase molecule. Beechey et al. (1974) previously reported that 'citreoviridin diacetate' was a reasonably potent inhibitor of ADP-stimulated respiration in rat liver mitochondria and of the ATPase of ox heart submitochondrial particles. We have found out subsequently that the sample used for this work was in fact a mixture of citreoviridin monoacetate (structure Ib) and an as yet unidentified citreoviridin derivative obtained in the acetylation procedure (P. E. Linnett, unpublished work) .
It is clear that the hydrogenation of citreoviridin monoacetate decreases its inhibitory potency dramatically. This suggests that the conjugated polyene system in citreoviridin (C-6 to C-13) is an important component in the binding of the inhibitor to the ATPase.
The reason for the stimulation of ATPase activity by citreoviridin diacetate and to a lesser extent by the monoacetate is not well understood. The present results do not enable us to determine whether the stimulatory and inhibitory citreoviridin acetatebinding sites are identical.
The lack of fluorescence enhancement when citreoviridin is bound to the ATPase is in direct contrast with the pronounced enhancement seen when aurovertin D associates with the ATPase (Lardy & Lin, 1969; Bertina et al., 1973; Chang & Penefsky, 1973 , 1974 Layton et al., 1973; Van de Stadt & Van Dam, 1974 ; Van de Stadt et al., 1974 ). The precise mechanism by which the fluorescence of aurovertin becomes less quenched when tightly bound to the ATPase is not known. Presumably the conformation in which citreoviridin is bound to the ATPase is such that an increased quantum yield is not obtained.
